Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Drosophila EYA Regulates the Immune Response against DNA through an Evolutionarily Conserved Threonine Phosphatase Motif

  • Xi Liu ,

    Contributed equally to this work with: Xi Liu, Teruyuki Sano, Yongsheng Guan

    Affiliations INSERM Equipe Avenir, CNRS UPR9022, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France, University of Strasbourg, Strasbourg, France

  • Teruyuki Sano ,

    Contributed equally to this work with: Xi Liu, Teruyuki Sano, Yongsheng Guan

    Current address: Molecular Pathology, Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, New York, United States of America

    Affiliations Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan, Solution Oriented Research for Science and Technology, and Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Kyoto, Japan

  • Yongsheng Guan ,

    Contributed equally to this work with: Xi Liu, Teruyuki Sano, Yongsheng Guan

    Affiliation INSERM Equipe Avenir, CNRS UPR9022, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France

  • Shigekazu Nagata , (SN); (HF)

    Affiliations Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan, Solution Oriented Research for Science and Technology, and Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Kyoto, Japan

  • Jules A. Hoffmann,

    Affiliations University of Strasbourg, Strasbourg, France, CNRS UPR9022, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France

  • Hidehiro Fukuyama (SN); (HF)

    Affiliation INSERM Equipe Avenir, CNRS UPR9022, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France

Drosophila EYA Regulates the Immune Response against DNA through an Evolutionarily Conserved Threonine Phosphatase Motif

  • Xi Liu, 
  • Teruyuki Sano, 
  • Yongsheng Guan, 
  • Shigekazu Nagata, 
  • Jules A. Hoffmann, 
  • Hidehiro Fukuyama


Innate immune responses against DNA are essential to counter both pathogen infections and tissue damages. Mammalian EYAs were recently shown to play a role in regulating the innate immune responses against DNA. Here, we demonstrate that the unique Drosophila eya gene is also involved in the response specific to DNA. Haploinsufficiency of eya in mutants deficient for lysosomal DNase activity (DNaseII) reduces antimicrobial peptide gene expression, a hallmark for immune responses in flies. Like the mammalian orthologues, Drosophila EYA features a N-terminal threonine and C-terminal tyrosine phosphatase domain. Through the generation of a series of mutant EYA fly strains, we show that the threonine phosphatase domain, but not the tyrosine phosphatase domain, is responsible for the innate immune response against DNA. A similar role for the threonine phosphatase domain in mammalian EYA4 had been surmised on the basis of in vitro studies. Furthermore EYA associates with IKKβ and full-length RELISH, and the induction of the IMD pathway-dependent antimicrobial peptide gene is independent of SO. Our data provide the first in vivo demonstration for the immune function of EYA and point to their conserved immune function in response to endogenous DNA, throughout evolution.


In humans, innate inflammation is frequently linked to various types of diseases, namely to autoimmune diseases [1]. However, it is still unclear in many instances how inflammation is initiated and chronically maintained. Pathogen invasions and/or subsequent changes of cellular integrity can cause inflammation and DNA has been reported to be a strong immune stimulator under such conditions [2], [3]. How cells recognize, and respond to, DNA are among the challenging questions in the field of inflammation, particularly in humans.

Several DNA recognition molecules have been recently identified. Among these are TLR-9 [4], Absent in Melanoma 2 (AIM2) [5], [6], Interferon gamma-inducible protein 16 (IFI16) [7], DNA-dependent activator of IRFs (DAI) [8], High-mobility group box protein 1 (HMGBP1) [9], and Leucine-rich repeat flightless-interacting protein 1 (LRRFIP1) [10]. These identifications were routinely based on the analysis of synthetic DNA-mediated immune reactions [11], [12]. Recent studies have addressed DNaseII deficient animals or cells to further our understanding on the DNA sensing mechanisms [13] and on the downstream signaling events.

DNaseII is an evolutionarily conserved acid DNase localized in lysosomes [14]. Macrophages in the fetal liver and thymus of DNaseII−/− mice cannot digest DNA of engulfed dead cells, or DNA of nuclei expelled from erythroid precursors [15], [16]. This results in their production of pro-inflammatory cytokines such as interferon-β (IFN-β) and tumor necrosis factor-α (TNF-α) [17], [18]. As a result of excessive cytokine production, DNaseII−/− mice suffer from anemia during embryonic stages and later, as adults, from polyarthritis. Crosses of DNaseII−/− mice with mice deficient for various immune response-related signaling molecules conclusively showed that (1) the DNA-dependent IFN-β gene expression is TLR-independent and IRF-3/7-dependent and that (2) the DNA-dependent TNF-α gene expression is both independent of TLR- and IRF-3/7- signaling [19], [20].

To elucidate the molecular mechanisms of DNA sensing in DNaseII−/− mice, Okabe et al. recently performed expression cloning and reported that Eyes absent 4 (EYA4) enhances the innate immune responses against DNA by activating IRF3 and NF-κB [21]. EYA was originally identified in Drosophila as a transcription factor that is essential for eye development [22]. Mammals have four EYA paralogs, EYA1-4. Mutations in human EYA1 cause branchio-oto-renal (BOR) syndrome, an autosomal dominant genetic disorder, affecting necks, ears, and kidneys [23], [24], [25]. EYA1−/− mice also show renal abnormalities and a conductive hearing loss similar to BOR syndrome [26]. EYA3−/− mice have a minor defect in locomotion with some deficits of respiratory, muscle and heart functions [27], and EYA4−/− mice show a defect in eustachian tube and middle ear [28]. EYA2−/− mice have not yet been generated. Several groups recently showed that EYA proteins carry C-terminally an evolutionarily conserved domain with tyrosine phosphatase activity [29], [30]. The detailed biochemical analysis by Okabe et al. [21]. Further identified a N-terminal threonine phosphatase domain in mouse EYA4, and showed that this domain is responsible for the innate immune responses observed against DNA.

Drosophila has a single orthologue of mammalian DNaseII. Interestingly, Mukae et al. found that flies carrying a hypomorphic mutation in the DNaseII gene (DNaseIIlo) constitutively express the anti-bacterial peptides Attacin A and Diptericin, but not the anti-fungal peptide Drosomycin [31]. Transcription of antimicrobial peptides in Drosophila is essentially under the control of two regulatory pathways: the IMD pathway (largely similar to the TNF/TNF-R pathway in mammals) controls the transcriptions of Attacin A and Diptericin, whereas the TOLL pathway regulates the transcription of Drosomycin [32]. The observations by Mukae et al. therefore suggest that excess DNA in the DNaseII deficient flies could activate the IMD pathway, but not the TOLL pathway.

Induction of immune response to endogenous DNA had not been established before the study of Mukae et al. in 2002 [31] and few studies have been devoted to this aspect of the innate immune response since. We decided to utilize Drosophila DNaseII deficient flies as a model to study the immune response against DNA. By taking Attacin A induction as a read-out, we first have addressed here the function of the eya gene of Drosophila. The fact that Drosophila has a single eya gene, would allow for precise in vivo analysis of the function of this gene in the immune response. We now show that EYA indeed plays a significant role in the expression of the IMD pathway-dependent antimicrobial peptide Attacin A in DNaseII-deficient flies. Interestingly, EYA is not involved in this Attacin A induction by Gram-negative bacteria as most potent stimulus in this pathway activation. In addition to the tyrosine-phosphatase activity, Drosophila EYA also carries a threonine-phosphatase activity at its N-terminus, as its mammalian counterparts. We demonstrate that this threonine phosphatase domain of Drosophila EYA is responsible for the innate immune responses against DNA in the DNaseII deficient model. In contrast, our results show that the tyrosine phosphatase domain governs eye development. We further reveal that EYA is associated with IKKβ and RELISH and AttacinA induction is independent of SO. Taken together with the Mukae et al and the Okabe et al studies in mice, our results point to a striking conservation of innate immune responses against endogenous DNA between Drosophila and mammals.


DNaseII deficiency-dependent expression of Attacin A in eya mutant background

We have first made use of three well-studied alleles of eya, which carry a 1.5 kb (eya1) or a 322 bp (eya2) deletion upstream of the transcription start site, and a nonsense loss-of-function mutation (eyacli-IID) that causes truncation of the EYA protein at amino acid 335 [33]. Eya1 or eya2 flies develop to adults deprived of eyes. Eyacli-IID flies are lethal at the embryonic stage. The DNaseIIlo allele has a missense G-to-A mutation at nucleotide 668, converting a Serine residue to an Aspargine residue at amino acid position 223, which results in a reduction of the acid DNase activity [33]. DNaseII mutants develop normally to the adult stage. Interestingly, these flies constitutively express the antimicrobial peptide Attacin A [31]. We generated eya1;DNaseIIlo, eya2;DNaseIIlo, and eyacli-IID;DNaseIIlo double mutant flies and monitored Attacin A expression. We noted that flies carrying homozygous eya and DNaseIIlo double mutations died at the pupal stage and we therefore used adult eya/+;DNaseIIlo flies to evaluate the effect of the eya gene in this context. As shown in Fig. 1A, DNaseII mutant flies constitutively expressed Attacin A, as previously reported [31]. In contrast, a heterozygous eya1 mutation combined with DNaseII deficiency significantly reduced Attacin A mRNA levels. Similar results were obtained with the eya2 and eyacli-IID alleles (Fig. 1A). To exclude possible effects of genetic background and/or aberrant development due to the gene deficiency/insufficiency, we generated an inducible eya/DNaseII knockdown system by RNA interference. In these experiments, we used established fly lines carrying dsRNAs for eya or/and DNaseII under a UAS promoter [34] and crossed them with a hsp-GAL4/tub-Gal80ts fly line [35]. After heat shock treatment, we measured the Attacin A mRNA levels on day 8. As shown in Fig. 1B, heat shock itself did not induce the Attacin A gene in the wild-type and GAL4 driver lines. The knockdown of the DNaseII gene, but not that of the eya gene, strongly activated Attacin A: Interestingly the knockdown of eya resulted in a strong reduction of the DNaseII knockdown-induced Attacin A expression. We observed a very low level of expression of Drosomycin in the Oregon-R strain, and this expression remained unchanged in knockdowns of eya and/or of DNaseII (Fig. 1C). These results provide an in vivo demonstration that Drosophila eya is involved in the immune response to DNA. Attacin A can be induced by Gram-negative bacterial challenge through the Drosophila IMD pathway. We investigated the role of EYA in the immune response during bacterial infection. As Fig. 1D shows, the Attacin A mRNA level was increased by bacterial challenge. However, its level was not altered in eya2 mutants. This result indicates that EYA plays a role in the immune response specifically against DNA. It is important to note that the genetic background affects the basal mRNA levels of Attacin A. However, Attacin A induction by DNaseII deficiency is consistent in both cases, mutant and RNAi transgenic flies. Two additional observations further support this conclusion: (1) cn bw-background DNaseII mutants established by backcrossing also show constitutive expression of Attacin A and (2) the rescue experiment showed that the Attacin A induction is dependent on DNaseII deficiency (X.L. and H.F., unpublished results).

Figure 1. EYA is involved in innate immune responses against DNA.

mRNA levels were determined for antimicrobial peptide genes by quantitative RT-PCR and normalized to Rp49 expression(also known as RpL32). The relative values are indicated against Oregon-R as wild-type control. (A) Attacin A expression for DNaseII, eya1/+;DNaseII, eya2/+;DNaseII, and eyacli-IID/+;DNaseII mutant flies. One-way ANOVA was performed and followed by Dunnett's multiple comparison test. * indicates statistically significance (p<0.0001) by comparing to Oregon-R. (B) Attacin A expression for single eya, single DNaseII, and double DNaseII and eya knockdown flies at 8 days after heat-shock treatment. dsRNAs were expressed using the GAL4-UAS system. The GAL4 driver line alone was included. Two-tailed unpaired Student's t-test was performed for statistic analysis. (C) Drosomycin expression using the same sets of flies as for (B). (D) Attacin A expression by E.coli challenge for w1118 as wild-type control and eya2 mutant flies. The value represents the average and standard deviation of 3–6 independent experiments. A pool of 5–20 adult flies per genotype was collected for each experiment.

In vitro functional analysis of the threonine phosphatase domain in recombinant Drosophila EYA mutant proteins

As mentioned in the Introduction, the four mammalian EYAs carry a C-terminal tyrosine phosphatase domain, also called EYA domain [36], which is conserved in flies. In addition, the mammalian and fly EYA proteins have a well-conserved N terminal threonine phosphatase domain with six tyrosine residues [21].

To characterize the Drosophila EYA threonine phosphatase activity in the present context, we expressed in mammalian 293 T cells a series of recombinant Drosophila EYA proteins: (1) Q335*, a nonsense mutation that causes truncation of the EYA protein at amino acid 335 and corresponds to the eyacli-IID loss-of-function allele [37] in the literature; this protein carries neither the tyrosine nor the threonine phosphatase motifs; (2) T497M, a missense mutation of the EYA domain (Fig. 2A), known as the eyaE11 allele [37]; (3) D497N; this allele was experimentally generated for recombinant protein EYA4 by a D493N replacement, which abolishes the tyrosine phosphatase activity [21], [29], [30]; (4) Y4 is an experimentally introduced allele, in which four tyrosine residues have been replaced in the threonine phosphatase domain, resulting in the total loss of the threonine phosphatase activity [21]; (5) WT refers to the wild-type EYA. After expression in 293 T cells, the recombinant proteins were purified with anti-Flag mAb and served to determine in vitro threonine-phosphatase activities using a phospho-threonine peptide. The results were as follows (Fig. 2B): The threonine-phosphatase activities of D493N and T497M were similar to that of WT. In contrast the threonine-phosphatase activities of the Y4 and that of Q335* were severely diminished. These results demonstrate that Drosophila EYA has a threonine phosphatase activity governed by the six-tyrosine-residues motif, and that this motif is not only evolutionarily but also functionally conserved from insects to mammals.

Figure 2. Threonine phosphatase domain in recombinant Drosophila EYA mutant proteins.

(A) Schematic view of Drosophila EYA with various mutant forms, WT, Y4, Q355*, D493N, and T497M. Two distinct phosphatase motifs are shown. Numbers indicate the positions of amino acid residues. and bold letter indicate evolutionarily conserved amino acids in the motifs. Arrows and dots in the EYA domain correspond to those shown in the magnified view with amino acid sequences. Two motifs in amino acid sequences of Mouse EYA4 are shown. (B) Drosophila EYA threonine phosphatase activities of WT, Q355*, Y4, D493N, T497M were measured. Free phosphate in mol is indicated. One-way ANOVA was performed and followed by Dunnett's multiple comparison test. * indicates statistically significance (p<0.001) by comparing to WT.

In vivo analysis of the role of the EYA threonine-phosphatase domain in Attacin A expression

With this information at hand, we next examined which of the threonine versus tyrosine phosphatase domains of Drosophila EYA is responsible for the innate immune responses against DNA. We generated, through bacteriophage ΦC31 integrase-mediated transgenesis [38], [39], fly lines expressing the various alleles of Drosophila EYA described above, i.e., WT, Q335*, T497M, D493N, and Y4. Expression was driven by a heat-shock promoter [22]. In brief, this transgenesis technique integrates a transgene (in our case, various forms of eya cDNAs) at the same specific site in the genome, allowing to make quantitative comparisons between different forms of EYA. We then crossed these eya transgenic flies to the homozygous eya2;DNaseIIlo strains. As mentioned above, homozygous eya2;DNaseIIlo flies show nearly full lethality; in the mutant series we observed some degree of rescue of the lethality with the WT eya transgenes, but barely with the other transgenes. We therefore decided to continue our experiments in an eya2 heterozygous and DNaseIIlo homozygous background. Under these conditions most of the flies survived. In WT flies, we observed a high level of Attacin A induction. When we compared this level to the transgenic line carrying the dual phosphatase inactive form, Q335*, we noted a dramatically lowered level of expression. Flies carrying a transgene in which only the tyrosine phosphatase function was lost (D493N and T497M) showed no significant difference with those of WT flies. Finally and most interestingly in the present context, flies carrying the Y4 construct, i.e. with an inactive threonine phosphatase domain and a wild type tyrosine phosphatase domain, showed the same level of expression as the forms with dual inactive phosphatase domains. Since the different effects of eya transgenes on the Attacin A expression could not be explained by the expression levels of the transgenes (Fig. S1, the same set of RNA in Fig. 3B was used), our results clearly point to the threonine phosphatase domain as the domain up-regulating the level of expression of Attacin A induced in the DNaseII deficient background.

Figure 3. In vivo analysis of the role of the EYA threonine-phosphatase domain in Attacin A expression.

(A) Schematic views of eya rescue transgenic fly lines. Various EYA transgenes were introduced on the X chromosome by ΦC31 transgenesis. These flies carry eya2 heterozygous and DNaseIIlo homozygous alleles on the 2nd and the 3rd chromosomes, respectively. The presence or absence of threonine and tyrosine phosphatase motifs in each transgene is shown by + or −. Bold lines in the transgenes are locations of replacement of amino acids. (B) Attacin A mRNA level was measured by quantitative RT-PCR and normalized to Rp49 expression(also known as RpL32). The relative values are indicated against Q355*. The value represents the average and standard deviation of three independent experiments. A pool of 5–7 adult flies per genotype was collected in each experiment. One-way ANOVA was performed (p = 0.0261) and followed by Dunnett's multiple comparison test. * indicates statistically significance (p<0.05) by comparing to WT.

The threonine phosphatase domain is not required for eye development

We next investigated the impact of the two different phosphatase activities of EYA on eye development. Although previous studies indicated that the tyrosine-phosphatase activity is required for eye development [29], [40], the possibility that the threonine phosphatase activity also affects eye development could not be excluded. As shown in Fig. 4, the eyes did not develop in flies carrying the eya2 mutation, as reported previously [22]. The inducible expression of the WT and Y4 forms of EYA at the stages from egg to pupae rescued the eyes absent phenotype. In contrast, the expression of the EYA forms of Q355*, D493N, and T497M could not rescue the phenotype. These results indicate that the tyrosine phosphatase activity of EYA is required for eye development, but that its threonine-phosphatase is dispensable.

Figure 4. Delineation of phosphatase activities for eye development.

Scanning electron micrographs of adult eyes. (A) eya2, (B) WT;eya2, (C) Y4;eya2, (D) Q355*;eya2, (E) D493N;eya2 (F) T497M;eya2 Scale bars correspond to 300 µm in length.

EYA associates with IKKβ and RELISH and AttacinA induction is independent of transcription factor SO

To obtain the mechanistic view of a link between EYA and the IMD pathway, we performed protein-protein association studies. Since the threonine phosphatase activity of EYA plays an important role for immune responses in DNaseII deficiency model, we reasoned to investigate two potential phospho-substrates of the IMD pathway: IKKβ and RELISH [41], [42]. When FLAG-MYC-tagged EYA and hemagglutinin (HA)-tagged IKKβ or RELISH were expressed in S2 cells, IKKβ and RELISH associated with EYA (Fig. 5A).

Figure 5. The link between EYA and the IMD pathway.

(A) Association studies between EYA and IKKβ or RELISH. FLAG-MYC-EYA was co-expressed with HA-IKKβ or HA-RELISH in S2 cells and immunoprecipitated (IP) with anti-FLAG antibody followed by immunobloting (IB). IKKβ and RELISH, or EYA were detected by anti-HA antibody or anti-MYC antibody, respectively. Five percent of total cell lysates as the input was shown on the top panel. (B) So-Eya co-expression induced the reporter activity. Luciferase activities of the reporter ARE-luciferase were measured and normalized to β-gal activities of Act5C-lacZ. The relative values against control of non-transfected and non-induced cells were shown. The value represents the average and standard deviation of 3–4 independent experiments. (C) Attacin A mRNA level was determined quantitative RT-PCR and normalized to Rp49 expression using the same sets in (B) except stimulated experimental set: S2 cells were stimulated by heat-killed E.coli (DH5α, heat-treated at 60°C for 1 h) for 16 h at 1∶20 MOI. The relative values against control of non-transfected, non-induced, and non-stimulated cells were shown. The value represents the average and standard deviation of 3–4 independent experiments. One-way ANOVA was performed (p<0.0001) and followed by Dunnett's multiple comparison test. * indicates statistically significance (p<0.0001) by comparing to control.

On the other hand, EYA binds to the homeobox transcription factor Sine Oculis (SO) [43]. To determine whether the AttacinA can be a target of the So-Eya complex, we co-transfected eya and so in S2 cells with reporter plasmid ARE-luciferase [44]. As previously reported [44], [45], co-transfection of eya and so activated ARE-luciferase 50-fold over the reporter alone (Fig. 5B). In this condition, AttacinA induction was not observed while heat-killed E.coli challenge induced AttacinA by more than 200-fold (Fig. 5C). These results indicate that AttacinA is not a target of the complex of EYA and SO.


We are interested in understanding how endogenous ligands can induce immune responses in Drosophila and whether the receptors and downstream signaling cascades are similar to those which are activated upon well-defined microbial stimuli (bacteria, fungi, virus) [46], [47]. The discoveries that mice and flies deficient for lysosomal DNase activities mount an immune response, as evidenced by the constitutive expression of IFN-β or of the antibacterial peptide Attacin A respectively, was of great interest in this context. The recent report by Okabe et al. that this innate response to undigested DNA is regulated in mice by the eya gene(initially discovered in Drosophila eye development) stimulated our interest in the potential role of this gene in the immune response of Drosophila. We provide four essential findings: (1) the immune response induced by undigested DNA in DNaseII deficient flies requires the eya gene; (2) the N-terminal threonine phosphatase domain of the EYA protein is responsible for this function, whereas that of the C-terminal tyrosine-phosphatase domain is dispensable; (3) EYA associates with IKKβ and RELISH and the So-Eya complex does not induce Attacin A; (4) the role of EYA proteins is conserved in this specific immune context between flies and mammals. We present the first in vivo demonstration for the role of the threonine-phosphatase domain of EYA proteins, which were so far surmised only on the basis of the in vitro studies in mice.

The two main questions, unanswered to date, pertain to (1) the identity of the DNA sensor (receptor) in flies; (2) the target molecule for the threonine-phosphatase activity of EYA.

As regards the first question, we have no firm data regarding DNA sensors in flies at present. In mammals, several molecules, play more or less well defined roles in DNA recognition, namely TLR9, AIM2, DAI, for which there are no homologues in flies. Identifying the DNA sensor in Drosophila is clearly a priority in the field. Of note, the sensor for DNA that accumulates in macrophages in DNaseII deficient mice has not yet been firmly identified. TLR9, which would appear as a good candidate, is not involved, as in DNaseII−/− TLR9−/− mice the innate immune response to accumulated DNA is unaffected.

How does EYA activate the IMD pathway to control expression of the Attacin A gene? Our transactivation and transcription assay indicates that AttacinA induction is not regulated by the So-Eya complex. Furthermore our protein-protein association studies suggest the link between EYA and the IMD pathway at the level of IKKβ and RELISH. It is noteworthy that EYA can associate with full-length RELISH. In general, the full-length RELISH is located in the cytoplasm and activated via two events: (1) phosphorylation by IKKβ and (2) cleavage by DREDD (similar to Caspase8/10), and eventually truncated N-terminal half of RELISH translocates to the nucleus to regulate transcriptions of target genes such as antimicrobial peptide genes [41], [48]. We propose that EYA can make a complex with IKKβ and RELISH in the cytoplasm, and activate the IMD pathway at this level. Interestingly, Eya2 mutants can respond to Gram-negative bacteria. These observations clearly exclude possibilities that EYA directly involves the phosphorylation of Serine 528 and Serine 529 of RELISH, which are targets of IKKβ and required for target gene expression. It is interesting to investigate the role of EYA on the phosphorylation status of Serines/Threonines in 107-aa C-terminal region in RELISH, which is also targets of IKKβ and required for the interaction between RELISH and IKKβ [41]. Of interest in the present context is the observation that both Drosophila and mammalian EYAs have two MAPK phosphorylation sites and that the Drosophila ERK and p38 MAPKs can phosphorylate Drosophila EYA in vitro [49]. Recently Morilo et al. demonstrated that NMO phosphorylates EYA and potentiates the transactivation function to enhance transcription of So-Eya target genes during eye specification and development [50]. Further, we now know that recombinant mouse EYA4 proteins produced in 293 T cells are phosphorylated (T.S., and S.N., unpublished results). The precise mechanism of dephosphorylation of target protein by EYA needs to be elucidated [51], [52].

In the mammalian system, EYA4 has been reported to be recruited by the dsRNA homologue poly (I:C) to the IPS-1 complex to activate the IRF3 and NF-κB pathways. This complex consists of various regulating molecules, namely RIG-I, STING, and NLRX1 [21]. No clear-cut homologue of any of these molecules were found in Drosophila till now (although RIG-I and Drosophila Dicer-2 share a helicase domain with the significant amino acid sequence similarity [53]). The components of the complex responsible for DNA-sensing remain to be revealed. EYA is the first identified molecule that is found in both insects and mammals in DNA sensing cascade.

Lastly, a surprising result of this study was that while both DNaseII- and eya1- or eya2- deficient flies develop normally, combining these two deficiencies is lethal at the pupal stage. The elucidation of this developmental arrest in eya1;DNaseIIlo or eya2;DNaseIIlo flies will hopefully shed light on DNA sensing and signal transduction in flies.

We anticipate that comparative studies on DNA sensing using Drosophila and mouse DNaseII deficient animals will facilitate the understanding of the molecular mechanisms of DNA-triggered innate inflammation.

Materials and Methods

Fly strains and maintenance

All flies were maintained with standard corn meal and yeast extract medium at 25°C at a light cycle- and humidity controlled-room. Oregon-R and w1118 were used as wild type controls. Flies used for AMP expression experiment were raised in antibiotics cocktail medium (100 µg/ml ampicillin, 50 µg/ml vancomycin, 100 µg/ml neomycin and 100 µg/ml metronidazole) [54] to reduce the risk of contaminating bacteria infection that could induce antimicrobial peptide gene expression [47] (Fig. S2). DNaseII[lo] (FBal0002709), In(2L)eya, eya[1] (FBst0003631) and eya[2](FBal0030759) mutant flies were obtained from the Bloomington stock center. Eya[cli-IID] (FBal0001705) mutant flies were gifted from Dr.Nancy N. BONINI. RNAi transgenic for DNaseII (NIG#7780R-3) and for eya (FBst0465312) were purchased from the Fly stocks of National Institute of Genetics, Japan and the Vienna Drosophila RNAi Center, Austria, respectively. Inducible ubiquitous driver, hsp-GAL4/tub-GAL80ts recombined fly line, was established by Dr.Ferrandon and described previously [35]. Heat shock-mediated GAL4 induction was performed as follows: all crossings with the hsp-GAL4/tub-GAL80ts driver were made at 18°C, three days old hatched flies were inoculated at 29°C for 2 days, at 37°C for 30 minutes, at 18°C for 30 minutes, at 37°C for 30 minutes, and then flies were kept at 29°C. Note that the incubation at 37°C was processed in the water bath. For ΦC31-mediated transgenesis previously described [38], [39], we utilized X-linked attB landing fly line VK6-ΦC31 (y[1] w[1118] PBac{yellow[+]-attP-9A}VK00006; +; +; M{eGFP.vas-int.Dm}ZH-102D) gifted from Dr. Koen VENKEN. By crossings, we generated and analyzed on series of transgenic rescue lines, e.g. hsp-EYA/Y; eya[2]/CyO;DNaseII[lo]/DNaseII[lo] (Fig. 3A).

Plasmids and Antibodies

The cDNA of eya was amplified from FBcl0108545 (Drosophila Genomics Resource Center) by PCR, cloned into pCR®8/GW/TOPO® TA cloning vector (Invitogen). The cDNAs of Ikkb (also called as ird5) and Rel were amplified using a cDNA library from S2 cells by PCR and cloned into pDONR207 vector (Invitogen). These pENTRY clones were verified by DNA sequencing and used for further plasmid constructions. Series of mutations were introduced by QuikChange® Lightning Site-Directed Mutagenesis Kit (Agilent Technologies) and the sequences were confirmed by DNA sequencing. These mutations includes: Y4 [21], D493N [21], T497M [37], and Q335* [37]. Primers used in this report are listed in Table S1. Based on pCaSpeR-hs (FBmc0000179) vector, the Gateway®-based destination vector pCaSpeR-attB-hsp-FW was generated for transgenesis. This vector containing the attB site for ΦC31-mediated transgenesis, Gateway® cassette fused with three repeated Flag sequence obtained from pTFW vector (the Drosophila Genomics Resource Center) for amino-terminal tagging. After LR reactions between pCaSpeR-attB-hsp-FW and pCR®8-N-dEYA (WT, Y4, D493N, T497M, and Q335*), series of pCaSpeR-attB-hsp-dEYA vectors were generated, followed by transgenesis using X-linked VK6-ΦC31. For the production of recombinant Drosophila EYAs, series of eya cDNAs in pCR®8/GW/TOPO® were transferred to mammalian expression vector pEF-BOS [55]. For biochemical analysis, Gateway®based destination vector pMT-HW was generated based on pHHW (the Drosophila Genomics Resource Center) and pMT/V5-His-A vector (Invitrogen). The vector contains Metallothionein-inducible promoter and hemagglutinin (HA) tag at amino-terminal. pAFMW destination vector contains Actin 5C promoter and dual tags of FLAG and MYC at amino-terminal. By LR reactions with these two destination vectors, we generated pMT-HA-IKKβ, pMT-HA-REL, and pAFMW-dEYA. For transactivation and transcription assay, pARE-luciferase, pRmHa3-Flag-SO and pRmHa3-Flag-EYA are kindly provided by Dr. Ilaria REBAY [44]. pACH110 containing Actin 5C promoter and LacZ gene was used for normalization of transfection efficiency. Anti-FLAG® M2 antibody (SIGMA-ALDRICH) for immunoprecipitation, Rabbit polyclonal anti-HA antibody (SIGMA-ALDRICH), anti-MYC antibody (BOEHRINGER INGELHEIM), and Horseradish Peroxidase (HRP)-conjugated anti-Rabbit or anti-mouse IgG antibody (SIGMA-ALDRICH) as secondary antibodies for immunoblotting were used in this study.

Protein expression, purification, and thereonine phosphatase activity assay

The Drosophila EYA proteins were produced in 293 T cells and purified using anti-Flag M2 affinity gel (SIGMA-ALDRICH) as described previously [21]. Briefly, series of pEF-BOS-dEYAs were transfected by Ca-Phosphate co-precipitation method, and cells were lysed and the supernatants after centrifugation was subjected to the purification. To quantify the phosphatase activity, the purified recombinant EYA was incubated with the phosphorylated synthetic peptide KR(pT)IRR at the concentration of 700 µM at 37°C for 60 min in 50 mM Tricine-KOH buffer (pH 8.0) containing 5 mM EDTA and 50 µM DTT using 0.5 pmol of a recombinant protein. The quantity of released phosphate was measured by colorimetric method using the malachite green-molybdate. The malachite green-ammonium molybdate phosphate complex was detected at 620 nm using a Micro Plate Reader (BioLumin 960).

RNA analysis

Total RNA was extracted from adult flies using RNeasy Mini kit (Qiagen) or NucleoSpin® RNAII kit (Macherey-Nagel). TaqMan® RNA-to-CT™ 1-Step Kit (Applied Biosystems) was used for quantitative RT-PCR with TaqMan® Gene Expression Assays primers and probes (Applied Biosystems) using 7500 Fast Real-Time PCR System (Applied Biosystems). These assays include Attacin A (Dm02362218_s1), Drosomycin (Dm01822006_s1), and RpL32(also known as Rp49, Dm02151827_g1). A pool of 5–20 flies was collected for each experiment. The expressions of the antimicrobial peptide genes were normalized to the expression of the RpL32 gene for each sample. Each assay was performed in duplicated manner and the average of duplicates was used for a single experiment data. For gene expression of eya in flies and AttacinA in S2 cells, total RNA was extracted from adult flies or cells using NucleoSpin® RNAII kit (Macherey-Nagel) or TRI REAGENT® RT(Molecular Research Center). Reverse transcription was performed by RevertAid™ H Minus Reverse Transcriptase (Fermentas). Fast SYBR® Green Master Mix (Applied Biosystems) was used for Quantitative RT-PCR with 7500 Fast Real-Time PCR System (Applied Biosystems). eya or AttacinA mRNA levels were quantified and normalized to mRNA level of Rp49. Both primers (Q-eya or Q-AttA primers, and Q-Rp49 primers) were listed in Table S1.

Bacteria challenge

Escherichia coli (1106C) at 37°C shaker (INNOVA-44R) were inoculated for 7 to 8 hours until OD600 reached 0.6–0.8. The pellet was collected and washed twice with PBS. Finally Escherichia coli was suspended in PBS and OD600 was adjusted to 2.0 for injection. We injected 13.8 nl to each female fly by NANOJECT II (Drummond Scientific) with customized capillary needles (Drummond scientific) crafted by flaming/brown micropipette puller model P-97 (Sutter Instrument). Six hours after injection flies were collected for RNA extraction to determine AMP expression.

Eye phenotype rescue experiment

Eggs were laid in culture media for 24 hours, and then processed the 1-hour heat shock at 37°C for every 8 hours using heat-blocks in the chamber until the white pupae stage. Hatched adult flies were counted for appearance of eye phenotype and frozen at −80°C. Frozen and dried flies were subjected to scanning electron microscope analysis using HITACHI TM-1000 Tabletop SEM (HITACHI).

S2 cell transactivation and transcription assay

Drosophila S2 cells were transiently transfected by calcium phosphate method with 2.5 µg each of pRmHa3-Flag-SO and pRmHa3-Flag-EYA, 10 µg of the reporter plasmid ARE-luciferase, and 1 µg of pACH110 for normalizing transfection efficiency. After 16-hour incubation, cells were washed with PBS and CuSO4 was added to the culture medium at the final concentration of 1 mM for induction. Cells were harvested 24 h later and lysed in 70 µL reporter lysis buffer (Promega). Ten micro liter or 2.5 µL of lysates were used for luciferase assay or β-galactosidase assay, respectively. Both assays were performed in duplicate manner using Mithras LB940 multimode microplate reader (Berthold technologies). Three or four independent transfections were made for each experimental set.

Immunoprecipitation and Immunoblotting

Six million of Drosophila S2 cells were transiently transfected with 5 µg each of pAFMW-dEYA and pMT-HA-IKKβ or pMT-HA-REL by calcium phosphate method. After 16-hour incubation, cells were washed with PBS and CuSO4 was added into the cell culture medium at the final concentration of 0.5 mM for induction. Cells were harvested 24 h later and then lysed with 200 µL of lysis buffer (50 mM Tris-HCl pH7.5, 10% Glycerol, 1% Triton X-100, 150 mM NaCl, 100 mM NaF, 5 µM ZnCl2, 1 mM Na3VO4, 10 mM EGTA pH8.0, 1 mM EDTA, protease inhibitor cocktails (ROCHE)) on ice for 30 min. After centrifugation, 10 µL of lysates were used for determining total protein expression level, and the rest was subjected to immunoprecipitation followed by immunoblotting. Anti-FLAG antibody was pre-incubated with 10 uL of Dynabeads® protein G (Invitrogen) in lysis buffer for 1 h at room tempreture followed by incubation with lysates for 2 h at 4°C. After washing 4 times by lysis buffer, the immunoprecipitates were boiled in 15 µL of 2× elution buffer (30% Glycerol, 0.15 M Tris-HCl PH6.8, 5% Sodium dodecyl sulfate, 0.02% Bromophenol blue, 0.72 M 2-Mercaptoethanol). For immunoblotting, proteins of immunoprecipitates and total lysates were resolved in Novex® 4–20% Tris-Glycine Gels (Invitrogen) followed by blotted to nylon membrane. Then the blot was incubated with anti-HA antibody(1∶1,000) or anti-Myc antibody(1∶1,000) followed by with Horseradish Peroxidase (HRP)-conjugated secondary antibodies(1∶15,000). The image was acquired by Fusion FX7 system (Vilber Lourmat) after incubated with Super Signal® West Dura substrates (Pierce). Three independent experiments were performed.


Two-tailed Student's t-test and one-way ANOVA were used for statistic analysis using Prism software.

Supporting Information

Figure S1.

EYA expression in transgenic rescue fly lines. The levels of eya mRNA were measured in rescue transgenic fly lines by quantitative RT-PCR and normalized to Rp49 mRNA levels. The relative expression values to Q355* are indicated. The value represents the average and standard deviation of three independent experiments. A pool of 5–7 adult flies per genotype was collected in each experiment.


Figure S2.

Bacteria growth in Antibiotics-treated flies. Three flies grown in normal or antibiotics medium were squashed in 100 µl of PBS and then spread on LB plates. The LB plates were incubated at 25°C for two days.



We are grateful to S.Gouillot for transgenesis, T.Nakamura, C.Makino, and V.Shilova for clonings, T.Rhinn-Tanaka for technical assistance, and V.Wolf and S.Risch for administrative supports. We thank the Bloomington Stock Center, the Genetic Strain Research Center of the National Institute of Genetics, Dr. K.Venken, Dr. MN.Bonini for providing fly stocks, and the Drosophila Genomics Resource Center and Dr.I,Rebay for plasmids.

Author Contributions

Conceived and designed the experiments: HF SN. Performed the experiments: XL TS YG. Analyzed the data: XL TS YG HF SN. Contributed reagents/materials/analysis tools: XL TS. Wrote the paper: XL HF SN JH.


  1. 1. Rock KL, Latz E, Ontiveros F, Kono H (2010) The sterile inflammatory response. Annu Rev Immunol 28: 321–342.
  2. 2. Nagata S, Hanayama R, Kawane K (2010) Autoimmunity and the clearance of dead cells. Cell 140: 619–630.
  3. 3. Barbalat R, Ewald SE, Mouchess ML, Barton GM (2011) Nucleic acid recognition by the innate immune system. Annu Rev Immunol 29: 185–214.
  4. 4. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740–745.
  5. 5. Burckstummer T, Baumann C, Bluml S, Dixit E, Durnberger G, et al. (2009) An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 10: 266–272.
  6. 6. Fernandes-Alnemri T, Yu JW, Juliana C, Solorzano L, Kang S, et al. (2010) The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 11: 385–393.
  7. 7. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, et al. (2010) IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11: 997–1004.
  8. 8. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, et al. (2007) DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448: 501–505.
  9. 9. Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, et al. (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462: 99–103.
  10. 10. Yang P, An H, Liu X, Wen M, Zheng Y, et al. (2010) The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat Immunol 11: 487–494.
  11. 11. Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, et al. (2006) A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 7: 40–48.
  12. 12. Stetson DB, Medzhitov R (2006) Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24: 93–103.
  13. 13. Nagata S (2005) DNA degradation in development and programmed cell death. Annual Review of Immunology. pp. 853–875.
  14. 14. Evans CJ, Aguilera RJ (2003) DNase II: genes, enzymes and function. Gene 322: 1–15.
  15. 15. Kawane K, Fukuyama H, Yoshida H, Nagase H, Ohsawa Y, et al. (2003) Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nature immunology 4: 138–144.
  16. 16. Kawane K, Fukuyama H, Kondoh G, Takeda J, Ohsawa Y, et al. (2001) Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science (New York, NY 292: 1546–1549.
  17. 17. Yoshida H, Okabe Y, Kawane K, Fukuyama H, Nagata S (2005) Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nature immunology 6: 49–56.
  18. 18. Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, et al. (2006) Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443: 998–1002.
  19. 19. Okabe Y, Kawane K, Akira S, Taniguchi T, Nagata S (2005) Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. The Journal of experimental medicine 202: 1333–1339.
  20. 20. Okabe Y, Kawane K, Nagata S (2008) IFN regulatory factor (IRF) 3/7-dependent and -independent gene induction by mammalian DNA that escapes degradation. European journal of immunology 38: 3150–3158.
  21. 21. Okabe Y, Sano T, Nagata S (2009) Regulation of the innate immune response by threonine-phosphatase of Eyes absent. Nature 460: 520–524.
  22. 22. Bonini NM, Leiserson WM, Benzer S (1993) The eyes absent gene: genetic control of cell survival and differentiation in the developing Drosophila eye. Cell 72: 379–395.
  23. 23. Abdelhak S, Kalatzis V, Heilig R, Compain S, Samson D, et al. (1997) A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet 15: 157–164.
  24. 24. Abdelhak S, Kalatzis V, Heilig R, Compain S, Samson D, et al. (1997) Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet 6: 2247–2255.
  25. 25. Kumar S, Kimberling WJ, Weston MD, Schaefer BG, Berg MA, et al. (1998) Identification of three novel mutations in human EYA1 protein associated with branchio-oto-renal syndrome. Hum Mutat 11: 443–449.
  26. 26. Xu PX, Adams J, Peters H, Brown MC, Heaney S, et al. (1999) Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet 23: 113–117.
  27. 27. Soker T, Dalke C, Puk O, Floss T, Becker L, et al. (2008) Pleiotropic effects in Eya3 knockout mice. BMC Dev Biol 8: 118.
  28. 28. Depreux FF, Darrow K, Conner DA, Eavey RD, Liberman MC, et al. (2008) Eya4-deficient mice are a model for heritable otitis media. J Clin Invest 118: 651–658.
  29. 29. Rayapureddi JP, Kattamuri C, Steinmetz BD, Frankfort BJ, Ostrin EJ, et al. (2003) Eyes absent represents a class of protein tyrosine phosphatases. Nature 426: 295–298.
  30. 30. Li X, Oghi KA, Zhang J, Krones A, Bush KT, et al. (2003) Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 426: 247–254.
  31. 31. Mukae N, Yokoyama H, Yokokura T, Sakoyama Y, Nagata S (2002) Activation of the innate immunity in Drosophila by endogenous chromosomal DNA that escaped apoptotic degradation. Genes & development 16: 2662–2671.
  32. 32. Hoffmann JA (2003) The immune response of Drosophila. Nature 426: 33–38.
  33. 33. Zimmerman JE, Bui QT, Liu H, Bonini NM (2000) Molecular genetic analysis of Drosophila eyes absent mutants reveals an eye enhancer element. Genetics 154: 237–246.
  34. 34. Dietzl G, Chen D, Schnorrer F, Su KC, Barinova Y, et al. (2007) A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 448: 151–156.
  35. 35. Cronin SJ, Nehme NT, Limmer S, Liegeois S, Pospisilik JA, et al. (2009) Genome-wide RNAi screen identifies genes involved in intestinal pathogenic bacterial infection. Science (New York, NY 325: 340–343.
  36. 36. Jemc J, Rebay I (2007) The eyes absent family of phosphotyrosine phosphatases: properties and roles in developmental regulation of transcription. Annu Rev Biochem 76: 513–538.
  37. 37. Bui QT, Zimmerman JE, Liu H, Bonini NM (2000) Molecular analysis of Drosophila eyes absent mutants reveals features of the conserved Eya domain. Genetics 155: 709–720.
  38. 38. Bischof J, Maeda RK, Hediger M, Karch F, Basler K (2007) An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proceedings of the National Academy of Sciences of the United States of America 104: 3312–3317.
  39. 39. Venken KJ, He Y, Hoskins RA, Bellen HJ (2006) P[acman]: a BAC transgenic platform for targeted insertion of large DNA fragments in D. melanogaster. Science (New York, NY 314: 1747–1751.
  40. 40. Tootle TL, Silver SJ, Davies EL, Newman V, Latek RR, et al. (2003) The transcription factor Eyes absent is a protein tyrosine phosphatase. Nature 426: 299–302.
  41. 41. Erturk-Hasdemir D, Broemer M, Leulier F, Lane WS, Paquette N, et al. (2009) Two roles for the Drosophila IKK complex in the activation of Relish and the induction of antimicrobial peptide genes. Proceedings of the National Academy of Sciences of the United States of America 106: 9779–9784.
  42. 42. Hacker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006: re13.
  43. 43. Pignoni F, Hu B, Zavitz KH, Xiao J, Garrity PA, et al. (1997) The eye-specification proteins So and Eya form a complex and regulate multiple steps in Drosophila eye development. Cell 91: 881–891.
  44. 44. Silver SJ, Davies EL, Doyon L, Rebay I (2003) Functional dissection of eyes absent reveals new modes of regulation within the retinal determination gene network. Mol Cell Biol 23: 5989–5999.
  45. 45. Kenyon KL, Yang-Zhou D, Cai CQ, Tran S, Clouser C, et al. (2005) Partner specificity is essential for proper function of the SIX-type homeodomain proteins Sine oculis and Optix during fly eye development. Dev Biol 286: 158–168.
  46. 46. Lemaitre B, Hoffmann J (2007) The host defense of Drosophila melanogaster. Annual review of immunology 25: 697–743.
  47. 47. Ferrandon D, Imler JL, Hetru C, Hoffmann JA (2007) The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections. Nature reviews 7: 862–874.
  48. 48. Stoven S, Silverman N, Junell A, Hedengren-Olcott M, Erturk D, et al. (2003) Caspase-mediated processing of the Drosophila NF-kappaB factor Relish. Proceedings of the National Academy of Sciences of the United States of America 100: 5991–5996.
  49. 49. Hsiao FC, Williams A, Davies EL, Rebay I (2001) Eyes absent mediates cross-talk between retinal determination genes and the receptor tyrosine kinase signaling pathway. Dev Cell 1: 51–61.
  50. 50. Morillo SA, Braid LR, Verheyen EM, Rebay I (2012) Nemo phosphorylates Eyes absent and enhances output from the Eya-Sine oculis transcriptional complex during Drosophila retinal determination. Dev Biol 365: 267–276.
  51. 51. Gottar M, Gobert V, Michel T, Belvin M, Duyk G, et al. (2002) The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein. Nature 416: 640–644.
  52. 52. Takehana A, Yano T, Mita S, Kotani A, Oshima Y, et al. (2004) Peptidoglycan recognition protein (PGRP)-LE and PGRP-LC act synergistically in Drosophila immunity. EMBO J 23: 4690–4700.
  53. 53. Galiana-Arnoux D, Dostert C, Schneemann A, Hoffmann JA, Imler JL (2006) Essential function in vivo for Dicer-2 in host defense against RNA viruses in drosophila. Nature immunology 7: 590–597.
  54. 54. Ryu JH, Kim SH, Lee HY, Bai JY, Nam YD, et al. (2008) Innate immune homeostasis by the homeobox gene caudal and commensal-gut mutualism in Drosophila. Science (New York, NY 319: 777–782.
  55. 55. Mizushima S, Nagata S (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic acids research 18: 5322.